Leuplinforection and prostate cancer stage iv Patient Reports March 19, 2010
Leuplinforection Side Effects Report #5789165-7
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on June 17, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer stage iv, metastatic pain and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: prostate cancer stage iv. Leuplinforection dosage: unknown. During the same period patient was treated with BICALUTAMIDE, FLUTAMIDE, ZOLEDRONIC ACID, ETODOLAC, TEPRENONE, ESTRAMUSTINE PHOSPHATE, BETAMETHASONE. Patient died on 01/07/2008.
Leuplinforection Side Effects Report #5775999-1
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on June 09, 2008. Male patient, 73 years of age, weighting 114.6 lb, was diagnosed with prostate cancer stage iv, metastases to bone and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: anorexia, depression
, metastases to bone, prostate cancer stage iv. Leuplinforection dosage: unknown. During the same period patient was treated with MORPHINE ELIXIR, BICALUTAMIDE, CHLORMADINONE ACETATE, ESTRAMUSTINE PHOSPHATE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, ZOLEDRONIC ACID, OXYCODONE. Patient died on 11/17/2007.Leuplinforection Side Effects Report #5214768-8
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cancer pain, gamma-glutamyltransferase increased, hot flush, malignant neoplasm progression, prostate cancer stage iv. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, DECADRON. Patient was hospitalized. Patient died.
Leuplinforection Side Effects Report #6105299-1
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Feb 20, 2009. Male patient, 66 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: prostate cancer stage iv. Leuplinforection dosage: unknown. During the same period patient was treated with FLUTAMIDE. Patient died on 06/20/2008.
Leuplinforection and prostate cancer stage iv 